Gene Information
Gene symbol: MYC
Gene name: v-myc myelocytomatosis viral oncogene homolog (avian)
HGNC ID: 7553
Synonyms: c-Myc, bHLHe39
Related Genes
| # | Gene Symbol | Number of hits |
| 1 | ACTB | 1 hits |
| 2 | BARD1 | 1 hits |
| 3 | BCL2L1 | 1 hits |
| 4 | BRCA1 | 1 hits |
| 5 | BRCA2 | 1 hits |
| 6 | CDKN1A | 1 hits |
| 7 | EGFR | 1 hits |
| 8 | ERBB2 | 1 hits |
| 9 | HRAS | 1 hits |
| 10 | RAD51 | 1 hits |
| 11 | RBBP8 | 1 hits |
| 12 | TP53 | 1 hits |
Related Sentences
| # | PMID | Sentence |
| 1 | 8605112 | The major types of genetic abnormalities that are frequently observed in breast tumors are amplification of protooncogenes (MYC, ERBB2) and DNA from chromosome band 11q13; mutation of TP53; and loss of heterozygosity from chromosomes and chromosome arms 1, 3p, 6q, 7q, 8p, 11, 13q, 16q, 17, 18q, and 22q. |
| 2 | 8605112 | Recently, linkage analyses of large families with a predisposition to breast cancer have been performed in order to map breast cancer susceptibility genes (TP53, BRCA1, BRCA2). |
| 3 | 8709940 | The major types of genetic alterations that are frequently observed in breast cancer are amplification of protooncogenes (MYC, ERBB2); mutation of TP53; and loss of heterozygosity on chromosomes 1, 3p, 8p, 11p, 13q, 17q, 17, and 22q. |
| 4 | 8709940 | Recently, two major distinct breast susptibility genes were isolated, namely BRCA1 and BRCA2. |
| 5 | 8718525 | Many oncogenes and tumour suppressor genes have been implicated, encoding proteins that are important at many levels of cell regulation, from cell surface molecules responding to external signals (eg ERBB2) to nuclear factors controlling gene transcription (eg TP53, MYC). |
| 6 | 8976125 | The major types of genetic alterations in breast cancer are amplification of protooncogenes (ERBB2 and MYC) and DNA from chromosome band 11q13; mutation of p53; and loss of heterozygosity on 1p, 3p, 8p, 11p, 13q, 16q, 17p, 17q, 18q. |
| 7 | 8976125 | Recently, two distinct familial breast cancer susceptibility genes, BRCA1 and BRCA2, have been isolated. |
| 8 | 9504854 | Fourteen cases of DCIS and 11 of DCIS with minimal invasion were analysed for mRNA levels of beta-actin, EGFR, c-cerbB2, MTS1, k-ras, RB, BRCA1, cyclin E, and c-myc genes. |
| 9 | 9674697 | Western blotting analysis revealed that pre-treatment of MDA-MB-453 cells with SF inhibited the ADR-induced decreases in the levels of Bcl-XL, an anti-apoptotic protein related to Bcl-2; and the dose-response and time course characteristics for SF-mediated increases in the Bcl-XL protein levels of ADR-treated cells were consistent with the degrees of protection against apoptosis observed under the same conditions. |
| 10 | 9674697 | In contrast to Bcl-XL, SF blocked ADR-induced increases in c-Myc and inhibited the expression of p21WAF1/CIP1 and of the BRCA1 protein in MDA-MB-453 cells. |
| 11 | 10195418 | The function of BRCA1 has been examined in gene knockout mice in which the nullizygous mice die early in utero, but this lethality can be partially rescued by a nullizygous p53 mutation. |
| 12 | 10195418 | Wild-type BRCA1 protein binds to a number of cellular proteins, including DNA repair protein Rad51, tumor suppressor p53, RNA polymerase II holoenzyme, RNA helicase A, CtBP-interacting protein, c-myc, BRCA1-associated RING domain protein (BARD1), BRCA2 protein, etc. |
| 13 | 10375022 | To understand the mechanism underlying the inhibition of proliferation by estradiol, we examined the expression of several growth related endogenous genes. c-Myc protooncogene expression was strongly inhibited by treatment with estradiol as was expression of BRCA1 and BRCA2 genes, which is in agreement with their mitogenic-dependent expression, while expression of beta-actin, a housekeeping gene, was not affected by hormone treatment. |